{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:07:02Z","timestamp":1791022022783,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.numecd.2010.11.008","type":"journal-article","created":{"date-parts":[[2011,4,6]],"date-time":"2011-04-06T20:00:27Z","timestamp":1302120027000},"page":"748-755","source":"Crossref","is-referenced-by-count":32,"title":["Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD)"],"prefix":"10.1016","volume":"22","author":[{"given":"D.","family":"Leonardis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Basta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Mallamaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cutrupi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pizzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Tripepi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tripepi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zoccali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2010.11.008_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2007.07.025","article-title":"Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications","volume":"196","author":"Basta","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2010.11.008_bib2","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","article-title":"Understanding RAGE, the receptor for advanced glycation end products","volume":"83","author":"Bierhaus","year":"2005","journal-title":"J Mol Med"},{"key":"10.1016\/j.numecd.2010.11.008_bib3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.jrn.2006.04.012","article-title":"Advanced glycation end products in renal failure","volume":"16","author":"Thornalley","year":"2006","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.numecd.2010.11.008_bib4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1523-1755.2004.00868.x","article-title":"Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes","volume":"66","author":"Thomas","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2010.11.008_bib5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1196\/annals.1333.088","article-title":"Advanced glycation end products in diabetes-associated atherosclerosis and renal disease: interventional studies","volume":"1043","author":"Jandeleit-Dahm","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.numecd.2010.11.008_bib6","doi-asserted-by":"crossref","first-page":"50019","DOI":"10.1074\/jbc.M409782200","article-title":"Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)","volume":"279","author":"Hanford","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.numecd.2010.11.008_bib7","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/2012","article-title":"Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation end products","volume":"4","author":"Park","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.numecd.2010.11.008_bib8","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.CIR.0000086014.80477.0D","article-title":"The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control","volume":"108","author":"Cipollone","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2010.11.008_bib9","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/01.ATV.0000190660.32863.cd","article-title":"Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and\u00a0atherosclerosis","volume":"25","author":"Koyama","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2010.11.008_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ki.2009.419","article-title":"Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in\u00a0patients with chronic kidney disease","volume":"77","author":"Basta","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2010.11.008_bib11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.RES.0000065620.39919.20","article-title":"A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes","volume":"92","author":"Candido","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2010.11.008_bib12","first-page":"293","article-title":"Pentosidine, carotid atherosclerosis and alterations in left ventricular geometry in hemodialysis patients","volume":"14","author":"Zoccali","year":"2001","journal-title":"J Nephrol"},{"issue":"Suppl.","key":"10.1016\/j.numecd.2010.11.008_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1523-1755.61.s80.7.x","article-title":"Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge","volume":"80","author":"Levin","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2010.11.008_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/j.ajkd.2008.02.302","article-title":"Kidney function and risk factors for left ventricular hypertrophy in untreated uncomplicated essential hypertension","volume":"52","author":"Perticone","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.numecd.2010.11.008_bib15","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1681\/ASN.V12122768","article-title":"Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis","volume":"12","author":"Zoccali","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2010.11.008_bib16","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from kidney disease: improving Global Outcomes (KDIGO)","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2010.11.008_bib17","first-page":"155A","article-title":"Modification of Diet in Renal Disease (MDRD) Study Group. a simplified equation to predict glomerular filtration rate from serum creatinine (abstract)","volume":"11","author":"Levey","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2010.11.008_bib18","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/0735-1097(94)00540-7","article-title":"Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk","volume":"25","author":"de Simone","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2010.11.008_bib19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.ki.5002650","article-title":"Confounding: what it is and how to deal with it","volume":"73","author":"Jager","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2010.11.008_bib20","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1046\/j.1523-1755.1998.06818.x","article-title":"Left ventricular hypertrophy in renal failure","volume":"68","author":"Amann","year":"1998","journal-title":"Kidney Int Suppl"},{"issue":"Suppl. 1","key":"10.1016\/j.numecd.2010.11.008_bib21","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.2215\/CJN.04860709","article-title":"Left ventricular mass in chronic kidney disease and ESRD","volume":"4","author":"Glassock","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2010.11.008_bib22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/oxfordjournals.ndt.a027813","article-title":"The concept of ventricular\/vascular coupling: functional and structural alterations of the heart and arterial vessels go in parallel","volume":"13","author":"London","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.numecd.2010.11.008_bib23","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1681\/ASN.V12112458","article-title":"Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients","volume":"12","author":"Benedetto","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2010.11.008_bib24","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1053\/ajkd.2003.50085","article-title":"Are advanced glycation end products cardiovascular risk factors in patients with CRF?","volume":"41","author":"Stein","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.numecd.2010.11.008_bib25","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1097\/01.ASN.0000067413.32377.CF","article-title":"Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy","volume":"14","author":"Suliman","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2010.11.008_bib26","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2119\/2007-00087.Koyama","article-title":"RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases","volume":"13","author":"Koyama","year":"2007","journal-title":"Mol Med"},{"key":"10.1016\/j.numecd.2010.11.008_bib27","doi-asserted-by":"crossref","first-page":"H1823","DOI":"10.1152\/ajpheart.01210.2007","article-title":"RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signalling in a murine model","volume":"294","author":"Aleshin","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.numecd.2010.11.008_bib28","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1172\/JCI200317115","article-title":"Central role of RAGE-dependent neointimal expansion in arterial restenosis","volume":"111","author":"Sakaguchi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2010.11.008_bib29","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0002-9440(10)63909-0","article-title":"RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy","volume":"162","author":"Wendt","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.numecd.2010.11.008_bib30","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1172\/JCI18058","article-title":"Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin super-family","volume":"114","author":"Bierhaus","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2010.11.008_bib31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1196\/annals.1333.077","article-title":"Advanced glycation end product receptor-mediated cellular dysfunction","volume":"1043","author":"Bierhaus","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.numecd.2010.11.008_bib32","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.ATV.0000160342.20342.00","article-title":"Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men","volume":"25","author":"Falcone","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2010.11.008_bib33","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/01.ATV.0000190660.32863.cd","article-title":"Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis","volume":"25","author":"Koyama","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2010.11.008_bib34","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1053\/j.ajkd.2005.12.028","article-title":"Soluble receptor for advanced glycation end products in patients with decreased renal function","volume":"47","author":"Kalousov\u00e1","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.numecd.2010.11.008_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000098811","article-title":"Pregnancy-associated plasma protein a and soluble receptor for advanced glycation end products after kidney transplantation","volume":"30","author":"Kalousova","year":"2007","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.numecd.2010.11.008_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5414\/CNP59088","article-title":"Serum levels of total homocysteine, homocysteine metabolites and of advanced glycation end-products (AGEs) in patients after renal transplantation","volume":"59","author":"Franke","year":"2003","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.numecd.2010.11.008_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.ATV.0000251502.88818.4b","article-title":"Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease","volume":"27","author":"Koyama","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2010.11.008_bib38","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/eurjhf\/hfp070","article-title":"Blockage of receptor for advanced glycation end products prevents development of cardiac dysfunction in db\/db type 2 diabetic mice","volume":"11","author":"Nielsen","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.numecd.2010.11.008_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cardfail.2006.11.009","article-title":"High serum level of pentosidine, an advanced glycation end product (AGE), is a risk factor of patients with heart failure","volume":"13","author":"Koyama","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.numecd.2010.11.008_bib40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cardfail.2007.10.019","article-title":"Soluble receptor for advanced glycation end products (RAGE) is a prognostic factor for heart failure","volume":"14","author":"Koyama","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.numecd.2010.11.008_bib41","unstructured":"Mallamaci F, Parlongo G, Catalano C, Puntorieri E, Zoccali C. Inflammation in chronic kidney disease: a pathophysiological and clinical overview. Nutr Ther Metab, in press."}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475310002747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475310002747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T06:53:27Z","timestamp":1637477607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475310002747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0939475310002747"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2010.11.008","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}